Tiziana Life Sciences PLC(TLSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TLSA Tiziana Life Sciences PLC

休市中 10-02 16:00:00 EDT

1.12

-0.02

-1.75%

盘后1.12

+0.000.00%

19:30 EDT

最高1.20	最低1.10	成交量43.68万
今开1.16	昨收1.14	日振幅8.77%
总市值1.42亿	流通市值7,149万	总股本1.27亿
成交额50.22万	换手率0.68%	流通股本6,383万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TLSA","market":"US","secType":"STK","nameCN":"Tiziana Life Sciences PLC","latestPrice":1.12,"timestamp":1790971200000,"preClose":1.14,"halted":0,"volume":436815,"hourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.12,"latestTime":"19:30 EDT","volume":54,"amount":59.71,"timestamp":1790983804778,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01754385964912263,"floatShares":63832528,"shares":127000000,"eps":-0.155821,"marketStatus":"休市中","change":-0.02,"latestTime":"10-02 16:00:00 EDT","open":1.16,"high":1.2,"low":1.1,"amount":502209.612657,"amplitude":0.087719,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.155821,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":2,"listingDate":1542690000000,"exchange":"NASDAQ","adjPreClose":1.14,"preHourTrading":{"tag":"盘前","latestPrice":1.1587,"preClose":1.14,"latestTime":"08:01 EDT","volume":583,"amount":663.801468,"timestamp":1790942492709,"change":0.0187,"changeRate":0.016404,"amplitude":0.037018},"postHourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.12,"latestTime":"19:30 EDT","volume":54,"amount":59.71,"timestamp":1790983804778,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6234337975971458,"impliedVol":1.1411,"impliedVolPercentile":0.8725},"requestUrl":"/m/hq/s/TLSA/wiki","defaultTab":"wiki","newsList":[{"id":"1106377233","title":"Tiziana宣布鼻内Foralumab治疗多发性硬化症2a期临床试验最后一名患者完成末次访视","url":"https://stock-news.laohu8.com/highlight/detail?id=1106377233","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106377233?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:15","pubTimestamp":1789989307,"startTime":"0","endTime":"0","summary":"Tiziana生命科学公司今日宣布，其鼻内给药Foralumab治疗多发性硬化症的2a期Inform-MS临床试验已迎来里程碑时刻——最后一位受试者圆满完成末次访视。Foralumab作为一种全人源抗CD3单克隆抗体，经鼻内途径给药后，有望通过调节免疫反应来缓解多发性硬化症相关的神经炎症。Tiziana管理层此前曾表示，Inform-MS试验旨在探索一种更为便捷、侵入性更低的治疗新模式，其最终结果备受投资者与学术界期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192254983","title":"Tiziana生命科学宣布与阿卜杜拉国王国际医学研究中心签署合作备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=1192254983","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192254983?lang=zh_cn&edition=full","pubTime":"2026-09-17 19:01","pubTimestamp":1789642899,"startTime":"0","endTime":"0","summary":"Tiziana生命科学公司正式宣告，已与阿卜杜拉国王国际医学研究中心达成合作备忘录的签署。这一举动，无疑为双方未来的深度协作铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139225640","title":"Tiziana生命科学宣布将在ALS Nexus 2026大会上展示鼻内福拉单抗2a期Banyan临床试验海报","url":"https://stock-news.laohu8.com/highlight/detail?id=1139225640","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139225640?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:01","pubTimestamp":1787569272,"startTime":"0","endTime":"0","summary":"Tiziana生命科学公司宣布，其鼻内福拉单抗2a期Banyan临床试验的海报将在ALS Nexus 2026会议上进行展示。ALS Nexus 2026是聚焦于肌萎缩侧索硬化症研究与治疗的重要学术会议。鼻内福拉单抗是Tiziana生命科学公司研发的一种创新性免疫调节剂，通过鼻腔给药途径递送，旨在调节免疫反应，延缓疾病进展。Tiziana生命科学公司致力于开发针对神经退行性疾病的突破性疗法，此次在海内外学术会议上亮相，也体现了其在ALS治疗领域的研究进展与决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143850695","title":"提济安娜生命科学公司：第三名多系统萎缩患者脑区SUV与SUVR分别降低34%和26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143850695","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143850695?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:03","pubTimestamp":1785495823,"startTime":"0","endTime":"0","summary":"提济安娜生命科学公司（Tiziana Life Sciences PLC）传来新进展——其针对多系统萎缩症（MSA）的临床研究再获积极数据。最新数据显示，第三名接受治疗的患者，其脑部特定区域的标准化摄取值（SUV）显著下降，幅度最高达34%；同时，标准化摄取值比值（SUVR）也出现明显降低，降幅达到26%。这一结果表明，该疗法在调节脑部代谢活动方面可能具有显著效果。尽管数据尚处于早期阶段，但这一趋势无疑为多系统萎缩症的治疗探索注入了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132073069","title":"Tiziana公布鼻内给药Foralumab治疗非活动性继发进展型多发性硬化症的新积极临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1132073069","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132073069?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:01","pubTimestamp":1779188512,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences PLC宣布了其鼻内给药Foralumab在治疗非活动性继发进展型多发性硬化症（非活动性SPMS）方面的新积极临床数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192701538","title":"截至2026年3月，Tiziana Life Sciences PLC鼻内Foralumab在长期治疗中耐受性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1192701538","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192701538?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:01","pubTimestamp":1779188509,"startTime":"0","endTime":"0","summary":"截至2026年3月的数据显示，Tiziana Life Sciences PLC旗下药物——鼻内给药的Foralumab，在延长治疗期间展现出良好的耐受性。这一进展为相关治疗领域提供了积极信号。\n长期用药的安全性是药物开发的关键考量。Foralumab在此方面的表现，为后续的临床研究与应用奠定了重要基础。其耐受性数据，将有助于进一步评估该疗法的潜力与风险。\n研究结果的持续积累，对于理解药物特性至关重要。Tiziana Life Sciences PLC所公布的这一信息，反映了该候选药物在安全性方面的积极态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518224432","title":"Tiziana Life Sciences Ltd盘中异动 急速拉升6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518224432?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613479,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Tiziana Life Sciences Ltd股票出现异动，股价急速上涨6.21%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1799.83%、382.57%、45.25%，振幅较大的相关个股有Xencor, Inc.、Y-Mabs Therapeutics, Inc.、Cadrenal Therapeutics, Inc.，振幅分别为99.13%、94.67%、9.44%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213119abf2fbc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213119abf2fbc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517169082","title":"Tiziana Life Sciences Ltd盘中异动 早盘大幅上涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517169082?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:07","pubTimestamp":1741273668,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时07分，Tiziana Life Sciences Ltd股票出现波动，股价快速上涨6.25%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1457.65%、672.25%、72.47%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为44.44%、41.05%、39.20%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230748a2629a1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306230748a2629a1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517948508","title":"Tiziana Life Sciences Ltd盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517948508?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:37","pubTimestamp":1741185450,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时37分，Tiziana Life Sciences Ltd股票出现波动，股价大幅下挫5.21%。截至发稿，该股报1.09美元/股，成交量3.6291万股，换手率0.03%，振幅9.20%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.63%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223730a260c999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223730a260c999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670096","title":"Tiziana Life Sciences Ltd盘中异动 早盘股价大跌7.08%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516670096?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:04","pubTimestamp":1741100668,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时04分，Tiziana Life Sciences Ltd股票出现波动，股价急速下跌7.08%。截至发稿，该股报1.05美元/股，成交量12.0333万股，换手率0.12%，振幅4.42%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.18%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230428abe7f9d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230428abe7f9d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516375916","title":"Tiziana Life Sciences Ltd盘中异动 急速下挫6.20%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516375916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516375916?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:56","pubTimestamp":1741013808,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时56分，Tiziana Life Sciences Ltd股票出现异动，股价快速下挫6.20%。截至发稿，该股报1.21美元/股，成交量14.606万股，换手率0.14%，振幅5.93%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.12%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225648989a16cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225648989a16cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514786563","title":"Tiziana Life Sciences Ltd盘中异动 大幅拉升12.40%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514786563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514786563?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753314,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Tiziana Life Sciences Ltd股票出现异动，股价快速上涨12.40%。截至发稿，该股报1.27美元/股，成交量21.9504万股，换手率0.21%，振幅6.35%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.16%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223515a258022e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223515a258022e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859813","title":"Tiziana Life Sciences Ltd盘中异动 早盘快速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859813?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:43","pubTimestamp":1740580989,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时43分，Tiziana Life Sciences Ltd股票出现异动，股价急速下跌5.20%。截至发稿，该股报0.910美元/股，成交量3.5985万股，换手率0.03%，振幅2.59%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体跌幅为0.48%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262243099893ad3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262243099893ad3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514012987","title":"Tiziana Life Sciences Ltd盘中异动 急速拉升6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514012987?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:17","pubTimestamp":1740503837,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时17分，Tiziana Life Sciences Ltd股票出现异动，股价快速拉升6.07%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Lava Therapeutics N.V.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Silexion Therapeutics Corp、Moleculin Biotech, Inc.较为活跃，换手率分别为1129.96%、953.10%、739.17%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为112.90%、87.83%、64.05%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601171896301482&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601171896301482&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513872023","title":"Tiziana Life Sciences Ltd盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513872023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513872023?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:09","pubTimestamp":1740409782,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时09分，Tiziana Life Sciences Ltd股票出现异动，股价急速拉升5.07%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为169.59%、73.81%、26.06%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230943abdb1730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230943abdb1730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513992432","title":"Tiziana Life Sciences Ltd盘中异动 早盘急速下挫5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513992432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513992432?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:54","pubTimestamp":1740149644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时54分，Tiziana Life Sciences Ltd股票出现波动，股价快速下跌5.54%。截至发稿，该股报0.850美元/股，成交量26.4735万股，换手率0.25%，振幅6.10%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.30%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221225404988de35f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221225404988de35f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512521481","title":"Tiziana Life Sciences Ltd盘中异动 快速拉升5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512521481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512521481?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:55","pubTimestamp":1739980533,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时55分，Tiziana Life Sciences Ltd股票出现异动，股价快速上涨5.72%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为554.33%、240.13%、177.67%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192355339628dac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192355339628dac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165014","title":"Tiziana Life Sciences Ltd盘中异动 急速拉升6.06%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165014?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889208,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Tiziana Life Sciences Ltd股票出现异动，股价急速拉升6.06%。截至发稿，该股报0.840美元/股，成交量5.7659万股，换手率0.06%，振幅1.26%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体跌幅为0.08%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223328a24aad3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223328a24aad3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511864617","title":"Tiziana Life Sciences Ltd盘中异动 临近收盘急速上涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511864617","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511864617?lang=zh_cn&edition=full","pubTime":"2025-02-15 04:51","pubTimestamp":1739566266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日04时51分，Tiziana Life Sciences Ltd股票出现异动，股价急速拉升5.35%。截至发稿，该股报0.780美元/股，成交量25.1935万股，换手率0.24%，振幅7.68%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体跌幅为0.84%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215045107abcf5676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215045107abcf5676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TLSA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511052681","title":"Tiziana Life Sciences Ltd盘中异动 大幅跳水6.42%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511052681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511052681?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457137,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Tiziana Life Sciences Ltd股票出现异动，股价快速下跌6.42%。截至发稿，该股报0.700美元/股，成交量3.2621万股，换手率0.03%，振幅1.34%。Tiziana Life Sciences Ltd股票所在的生物技术行业中，整体涨幅为0.17%。Tiziana Life Sciences Ltd公司简介：Tiziana Life Sciences Ltd 是一家临床阶段生物技术公司，专门开发治疗神经退行性疾病和肺部疾病的变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223217abcdb25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223217abcdb25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TLSA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tizianalifesciences.com","stockEarnings":[{"period":"1week","weight":0.1089},{"period":"1month","weight":0.2024},{"period":"3month","weight":-0.145},{"period":"6month","weight":-0.104},{"period":"1year","weight":-0.44},{"period":"ytd","weight":-0.2483}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tiziana Life Sciences Ltd最初于1998年2月11日根据英格兰和威尔士法律注册成立。该公司是一家临床阶段的生物技术公司，专门开发神经退行性疾病和神经炎症性疾病的转化疗法。公司临床管线包括非活动性继发性进展性多发性硬化症、多系统萎缩症、阿尔茨海默症、肌萎缩侧索硬化症的药物资产。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.062066},{"month":2,"riseRate":0.125,"avgChangeRate":0.000048},{"month":3,"riseRate":0.375,"avgChangeRate":0.130911},{"month":4,"riseRate":0.625,"avgChangeRate":0.144279},{"month":5,"riseRate":0.5,"avgChangeRate":0.187138},{"month":6,"riseRate":0.375,"avgChangeRate":-0.011823},{"month":7,"riseRate":0.375,"avgChangeRate":0.26158},{"month":8,"riseRate":0.25,"avgChangeRate":-0.130353},{"month":9,"riseRate":0.375,"avgChangeRate":0.001357},{"month":10,"riseRate":0.375,"avgChangeRate":-0.066149},{"month":11,"riseRate":0,"avgChangeRate":-0.127748},{"month":12,"riseRate":0,"avgChangeRate":-0.132657}],"exchange":"NASDAQ","name":"Tiziana Life Sciences PLC","nameEN":"Tiziana Life Sciences PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tiziana Life Sciences PLC(TLSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tiziana Life Sciences PLC(TLSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tiziana Life Sciences PLC,TLSA,Tiziana Life Sciences PLC股票,Tiziana Life Sciences PLC股票老虎,Tiziana Life Sciences PLC股票老虎国际,Tiziana Life Sciences PLC行情,Tiziana Life Sciences PLC股票行情,Tiziana Life Sciences PLC股价,Tiziana Life Sciences PLC股市,Tiziana Life Sciences PLC股票价格,Tiziana Life Sciences PLC股票交易,Tiziana Life Sciences PLC股票购买,Tiziana Life Sciences PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tiziana Life Sciences PLC(TLSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tiziana Life Sciences PLC(TLSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}